Vaxcyte (PCVX) Other financing activities (2020 - 2024)
Vaxcyte (PCVX) reported Other financing activities of $9.3 million for Q3 2024, up 258.39% year-over-year from $2.6 million in Q4 2023, and up 1552.39% quarter-over-quarter from $565000.0 in Q2 2024.
Vaxcyte (PCVX) Other financing activities (2020 - 2024) Analysis & Trends
Vaxcyte (PCVX) has 4 years of Other financing activities data on file, last reported at $9.3 million in Q3 2024.
- Other financing activities for Q3 2024 came in at $9.3 million, up 258.39% year-over-year; the trailing twelve-month figure through Sep 2024 was $20.6 million (up 481.75% YoY), and the FY2023 annual result was $3.9 million, up 350.17% from the prior year.
- Other financing activities advanced to $9.3 million in Q3 2024 per PCVX's latest filing, from $565000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $9.3 million in Q3 2024 and troughed at -$3.4 million in Q4 2020.
- A 4-year average of $2.1 million and a median of $794000.0 in 2022 frame the typical range for Other financing activities.
- On a YoY basis, Other financing activities climbed as much as 354.75% in 2024 and fell as far as 164.02% in 2024.
- A 4-year view of Other financing activities shows it stood at -$3.4 million in 2020, then surged by 125.56% to $861000.0 in 2022, then jumped by 762.02% to $7.4 million in 2023, then gained by 25.79% to $9.3 million in 2024.
- Business Quant data shows PCVX's Other financing activities at $9.3 million in Q3 2024, $565000.0 in Q2 2024, and $3.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 9.34 Mn |
| Sep 30, 2024 | 9.34 Mn |
| Jun 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 565,000.00 |
| Mar 31, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 214,000.00 |
| Mar 31, 2023 | 727,000.00 |
| Mar 31, 2023 | 727,000.00 |
| Sep 30, 2022 | 861,000.00 |
| Sep 30, 2022 | 861,000.00 |
| Dec 31, 2020 | -3.37 Mn |
| Dec 31, 2020 | -3.37 Mn |
| Sep 30, 2020 | -135,000.00 |
| Sep 30, 2020 | -135,000.00 |